Literature DB >> 16780338

Synthesis, reactivity, and X-ray crystal structure of some mixed-ligand oxovanadium(V) complexes: first report of binuclear oxovanadium(V) complexes containing 4,4'-bipyridine type bridge.

Manas Sutradhar1, Gurunath Mukherjee, Michael G B Drew, Saktiprosad Ghosh.   

Abstract

Reaction of the tridentate ONO Schiff-base ligand 2-hydroxybenzoylhydrazone of 2-hydroxybenzoylhydrazine (H2L) with VO(acac)2 in ethanol medium produces the oxoethoxovanadium(V) complex [VO(OEt)L] (A), which reacts with pyridine to form [VO(OEt)L.(py)] (1). Complex 1 is structurally characterized. It has a distorted octahedral O4N2 coordination environment around the V(V) acceptor center. Both complexes A and 1 in ethanol medium react with neutral monodentate Lewis bases 2-picoline, 3-picoline, 4- picoline, 4-amino pyridine, imidazole, and 4-methyl imidazole, all of which are stronger bases than pyridine, to produce dioxovanadium(V) complexes of general formula BH[VO2L]. Most of these dioxo complexes are structurally characterized, and the complex anion [VO2L]- is found to possess a distorted square pyramidal structure. When a solution/suspension of a BH[VO2L] complex in an alcohol (ROH) is treated with HCl in the same alcohol, it is converted into the corresponding monooxoalkoxo complex [VO(OR)L], where R comes from the alcohol used as the reaction medium. Both complexes A and 1 produce the 4,4'-bipyridine-bridged binuclear complex [VO(OEt)L]2(mu-4,4'-bipy) (2), which, to the best of our knowledge, represents the first report of a structurally characterized 4,4'-bipyridine-bridged oxovanadium(V) binuclear complex. Two similar binuclear oxovanadium(V) complexes 3 and 4 are also synthesized and characterized. All these binuclear complexes (2-4), on treatment with base B, produce the corresponding mononuclear dioxovanadium(V) complexes (5-10).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16780338     DOI: 10.1021/ic051120g

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  5 in total

1.  Bis[2,4-penta-nedionato(1-)]bis-[4,4,5,5-tetra-methyl--2-(4-pyrid-yl)-imidazoline-1-oxyl 3-oxide]manganese(II).

Authors:  Ying Liu; Qingpeng He; Xianxi Zhang; Zechun Xue; Chunyan Lv
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-22

2.  Tris[2-(propyl-imino-meth-yl)phenolato-κN,O]iron(III).

Authors:  Lujiang Hao; Chunhua Mu; Binbin Kong
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-06-25

3.  Pharmacological evaluation and preparation of nonsteroidal anti-inflammatory drugs containing an N-acyl hydrazone subunit.

Authors:  Thais Regina Ferreira de Melo; Rafael Consolin Chelucci; Maria Elisa Lopes Pires; Luiz Antonio Dutra; Karina Pereira Barbieri; Priscila Longhin Bosquesi; Gustavo Henrique Goulart Trossini; Man Chin Chung; Jean Leandro dos Santos
Journal:  Int J Mol Sci       Date:  2014-04-04       Impact factor: 5.923

4.  Oxido- and Dioxido-Vanadium(V) Complexes Supported on Carbon Materials: Reusable Catalysts for the Oxidation of Cyclohexane.

Authors:  Manas Sutradhar; Marta A Andrade; Sónia A C Carabineiro; Luísa M D R S Martins; Maria de Fátima C Guedes da Silva; Armando J L Pombeiro
Journal:  Nanomaterials (Basel)       Date:  2021-05-31       Impact factor: 5.076

5.  (Ethano-lato-κO)[N'-(3-meth-oxy-2-oxidobenzyl-idene-κO(2))benzo-hydrazidato-κ(2)N',O]oxidovanadium(V).

Authors:  Xiao-Hua Chen; Qiong-Jie Wu; Li-Juan Chen; Ming-Xing Yang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.